Mar. 19, 2015 12:55 PM ET | Includes: ADMA, APHB, ASPS, CGIX, DO, DYN, ENOC, FDS, GGP, MMI, MPW, NEE, PCLN, PSA, RGS, RXDX, SANW, SSNC, TCB, TWTR by: InsiderInsights Summary Tables of the top insider purchases and sales filed with the SEC on ... Seeking Alpha, 1 week ago
2 images for "Cgix"
Cancer Genetics, Inc. to Present Results From Three Major Clinical Research Collaborations at USCAP Showcasing the Importance of Genomic Panels for Cancer Identification and Management
(GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or "the company") announced today that it will present three posters at USCAP, the annual meeting of the United States and Canadian Academy of Pathology, March 23-24 at the Hynes ...Digital Producer, 1 week ago Cancer Genetics, Inc. (CGIX) in Focus: Stock Jumps 5.3% Zacks.com, 2 weeks ago Cancer Genetics' (CGIX) CEO Panna Sharma on Q4 2014 Results - Earnings Call Transcript Seeking Alpha, 2 weeks ago Cancer Genetics to Report Fourth Quarter and Fiscal Year 2014 Financial Results on Thursday, March 12 Individual.com, 1 month ago
Cancer Genetics (NASDAQ:CGIX) Director John Pappajohn acquired 50,000 shares of Cancer Genetics stock on the open market in a transaction dated Tuesday, March 17th. The stock was purchased at an average cost of $7.36 per share, with a total value of ...SleekMoney, 1 week ago
Here is a breakdown of insider trading activity for Wednesday, March 18th: Aimia (TSE:AER) insider Financial Corporation Jaguar purchased 5,000 shares of Aimia stock in a transaction that occurred on Tuesday, March 17th. The shares were purchased ...SleekMoney, 1 week ago
Investing in small-cap health care companies can be tricky, with stocks that can soar or crash based on the results of a single clinical trial. However, equities.com's Small-Cap Stars , our proprietary list of small-cap companies with ...Equities.com, 1 month ago
Investment Analysts Ratings Reiterations for March, 15th (AVGR, BIIB, BIOA, CCG, CGIX, CRME, MED, MILL, MONIF, NGVC)
Investment Analysts ratings reiterations for Sunday, March 15th: Avinger (NASDAQ:AVGR) had its buy rating reiterated by analysts at Canaccord Genuity. Canaccord Genuity currently has a $18.00 target price on the stock. Avinger (NASDAQ:AVGR) had its ...Mideast Time, 2 weeks ago Cancer Genetics's Buy Rating Reaffirmed at Cantor Fitzgerald (CGIX) SleekMoney, 2 weeks ago
Shares of Cancer Genetics (NASDAQ:CGIX) saw strong trading volume on Friday following a stronger than expected earnings report, AR Network reports. 221,503 shares were traded during trading, an increase of 197% from the previous session's volume of ...Mideast Time, 2 weeks ago Cancer Genetics (CGIX) Issues Quarterly Earnings Results WKRB News, 2 weeks ago
Cancer Genetics (NASDAQ:CGIX) has been given an average broker rating score of 1.00 (Strong Buy) from the two brokers that provide coverage for the stock, Zacks Investment Research reports. Two analysts have rated the stock with a strong buy rating.WKRB News, 2 weeks ago Analysts Set $14.38 Price Target for Cancer Genetics (NASDAQ:CGIX) Mideast Time, 1 month ago Analysts Expect Cancer Genetics to Announce ($0.48) EPS (NASDAQ:CGIX) Ticker Report, 1 month ago
Vertex Pharma's Disappointing VX-661 Trial Results Isn't The End; Arch Therapeutics Announces Positive Safety Results for AC5 Surgical Hemostatic Device(TM)
Below is a look at some of the headlines for companies that made news in the healthcare sector on March 23, 2015. Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) shares sank Monday on results from a trial of one of its cystic fibrosis ...BioMedReports, 1 week ago Acasti Gains Ahead Of Expected Phase II Results; Cyberonics Plans To Merge With Milan's Sorin SpA BioMedReports, 1 month ago Celsus' Lead Drug Flunks Phase II Trial; Acorda Shares Still Down 7% In A Week BioMedReports, 1 month ago NeuroBioPharm's Shareholders Approve Arrangement With Neptune; Aileron Initiates Phase 1 Cancer Study of ALRN-6924 BioMedReports, 1 month ago
On a per-share basis, the Rutherford, New Jersey-based company said it had a loss of 55 cents. Losses, adjusted for costs related to mergers and acquisitions, came to 49 cents per share. The diagnostics company posted revenue of $4 million in the ...Investor's Business Daily, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!